Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.

The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, according to a study published online Feb. 4 in The Lancet. Nirosen ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...

The nonclinical pharmacokinetic (PK) and pharmacodynamic (PD) study was conducted to examine the effects of semaglutide ...

It has been likened to Botox; it has been compared to retinol; it’s been incorporated into skincare products the world over: ...

A couple of months ago, healthcare equity research analyst Jared Holz from Mizuho spoke about Viking potentially being an ...

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

The idea behind viscosupplementation is that replacing this hyaluronic acid may help reduce symptoms. Your provider may first inject a numbing medicine into the space around your knee joint. They may ...

Subsequently, we integrated the Ang2 peptide segment into M2 microglia to obtain Ang2-EVs, which could successfully target the site of spinal cord injury. However, in order to improve the function of ...